p53, cancer and the immune response

Blagih, Julianna, Buck, Michael D., Vousden, Karen H.·2020·Journal of Cell Science

DOI 10.1242/jcs.237453

Cited by (338)

Items 101–200 of 338

p53 promotes antiviral innate immunity by driving hexosamine metabolism
Wenjun Xia, Peng Jiang · 2024 · Cell Reports
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
Tarana Gupta, Nikhil Sai Jarpula · 2024 · World Journal of Hepatology
Network Toxicology and Molecular Docking Analysis of Tetracycline-Induced Acute Pancreatitis: Unveiling Core Mechanisms and Targets
Hang Lei, Yan Jun Wu, Wenjun Ma, Jiaqi Yao, Pengcheng Zhang, Yong Tian, Yuhong Jiang, Zhijun Xie, Lv Zhu, Wenfu Tang · 2024 · Toxics
CTPS1 inhibition suppresses proliferation and migration in colorectal cancer cells
Fahong Wu, Yudong Mao, Tao Ma, Xiaoli Wang, Hangzhi Wei, Tianwei Wang, Jia Wang, Youcheng Zhang · 2022 · Cell Cycle
The Role of Cdo1 in Ferroptosis and Apoptosis in Cancer
Xiaoyi Chen, Ansgar Poetsch · 2024 · Biomedicines
m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer
Mengyu Sun, Meng Xie, Tongyue Zhang, Yijun Wang, Wenjie Huang, Limin Xia · 2021 · Frontiers in Immunology
The In Vitro Anti-Cancer Activities and Mechanisms of Action of 9-Methoxycanthin-6-one from Eurycoma longifolia in Selected Cancer Cell Lines
Nurhanan Murni Yunos, Nor Datiakma Mat Amin, Muhammad Haffiz Jauri, Sui Kiong Ling, Nor Hasnida Hassan, Nor Jannah Sallehudin · 2022 · Molecules
Exploring the future of research in the Tp53 field
Arnold J. Levine · 2022 · Cell Death and Differentiation
TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study
Yuting Tao, Xia Li, Yushan Zhang, Liangyu He, Qinchen Lu, Yaobang Wang, Li-Xin Pan, Zhenxing Wang, Chao Feng, Yuanliang Xie et al. · 2022 · Frontiers in Genetics
Harnessing p53 for targeted cancer therapy: new advances and future directions
Zdeněk Andrysík, Joaquin Maximiliano Espinosa · 2025 · Transcription
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs
Bolong Xu, Ayitila Maimaitijiang, Dawuti Nuerbiyamu, Zhengding Su, Wenfang Li · 2025 · Biomolecules
Identification of an immune classification for cervical cancer and integrative analysis of multiomics data
Xintong Lyu, Guang Li, Qiao Qiao · 2021 · Journal of Translational Medicine
The CDK4/6 Inhibitor Palbociclib Induces Cell Senescence of High-grade Serous Ovarian Cancer Through Acetylation of p53
Cong Ye, Yan H. Cheng, Xiaohong Qian, Bo Zhong, Jinchun Ma, Hongling Guo · 2024 · Biochemical Genetics
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients
Αναστάσιος Γκουντάκος, Pietro Delfino, Rita Teresa Lawlor, Aldo Scarpa, Vincenzo Corbo, Emilio Bria · 2021 · Therapeutic Advances in Medical Oncology
Empirical relationships between compressive and flexural strength of concrete containing recycled asphalt material for pavement applications using different specimen configurations
Carlos Rodolfo Marín-Uribe, R. Navarro-Gaete · 2021 · Materiales de Construcción
Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
Yupeng Jiang, Wenhao Ouyang, Chenzi Zhang, Yunfang Yu, Herui Yao · 2022 · Frontiers in Cell and Developmental Biology
Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis
Lucia Hároníková, Pavlína Zatloukalová, Martina Kucerikova, Nela Friedlová, Zuzana Tylichová, Filip Zavadil Kokas, Ted R. Hupp, Philip John Coates, Bořivoj Vojtěšek · 2024 · Cellular & Molecular Biology Letters
Robust Prediction of Immune Checkpoint Inhibition Therapy for Non-Small Cell Lung Cancer
Jiehan Jiang, Zheng Jin, Yiqun Zhang, Ling Peng, Yue Zhang, Zhiruo Zhu, Yaohui Wang, De Tong, Yining Yang, Jianfei Wang et al. · 2021 · Frontiers in Immunology
Revealing the Mechanism of Astragali Radix against Cancer-Related Fatigue by Network Pharmacology and Molecular Docking
Yi Xie, Kainan Zhou, Yan Wang, Shuhan Yang, Suying Liu, Xueqian Wang, Ying Zhang · 2021 · Evidence-based Complementary and Alternative Medicine
Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment
Pengwei Cao, Lei Liu, Zi-Han Li, Feng Cao, Fubao Liu · 2022 · Frontiers in Genetics
Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review)
Pengkai Han, Junhao Zhou, Jianhua Xiang, Qiping Liu, Kai Sun · 2022 · Oncology Reports
Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects
Jinyi Zhang, Xueqing Kong, Boyan Zhou, Rui Li, Zhaoan Yu, Jinrong Zhu, Qing Xi, Yan Li, Zichao Zhao, Rongxin Zhang · 2025 · Molecular Aspects of Medicine
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer
Yun Gu, Mengyao Sun, Hanji Fang, Fei Shao, Chao Lin, Hao Liu, Li He, Hongyong He, Ruochen Li, Jieti Wang et al. · 2024 · British Journal of Cancer
Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma
Jinglin Mi, Shanshan Ma, Wei Chen, Min Kang, Meng Michelle Xu, Chang Liu, Bo Li, Fang Wu, Fengju Liu, Yong Zhang et al. · 2022 · Frontiers in Oncology
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival
Hiroshi Yokouchi, Hiroshi Nishihara, Toshiyuki Harada, Shigeo Yamazaki, Hajime Kikuchi, Satoshi Oizumi, Hidetaka Uramoto, Fumihiro Tanaka, Masao Harada, Kenji Akie et al. · 2020 · Heliyon
TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer
Zhang, Feng, Zhong, Wenhui, Li, Honghao, Huang, Kaijun, Yu, Min, Liu, Yubin · 2021 · Frontiers in Cell and Developmental Biology
P53 Alleviates the Progression of Periodontitis by Reducing M1-type Macrophage Differentiation
Tingting Liu, Dongru Chen, Shanshan Tang, Zhaolei Zou, Fangyi Yang, Yutian Zhang, Dikan Wang, Huanzi Lu, Guiqing Liao, Xiangqi Liu · 2024 · Inflammation
SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy
Xiangyuan Luo, Zerui Zhang, Siwen Li, Yijun Wang, Mengyu Sun, Dian Xing Hu, Junqing Jiang, Yufei Wang, Xiaoyu Ji, Xiaoping Chen et al. · 2023 · International Immunopharmacology
The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells
Fei Wang, Ali Bashiri Dezfouli, Gabriele Multhoff · 2024 · Molecular Immunology
The Development and Application of Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma
Laura Sun, Jason T. Romancik · 2025 · Journal of Personalized Medicine
m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment
Fei Liu, Xiaopeng Yu, Guijin He · 2021 · Journal of Oncology
FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
Qingqing Wu, Tingru Shao, Guangzhao Huang, Zenan Zheng, Yingtong Jiang, Weisen Zeng, Xiaozhi Lv · 2022 · Biomolecules
Milk exosomal microRNAs: friend or foe?—a narrative review
Bodo Clemens Melnik, Ralf Weiskirchen, Gerd Schmitz · 2022 · ExRNA
TP53-mutated MDS and AML: immune dysregulation, tumor microenvironment, and emerging therapeutic strategies
Marwah M. Albakri · 2025 · Frontiers in Oncology
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling
Samuel Benjamin Reynolds, Kristen Marie Pettit, Malathi Kandarpa, Moshe Talpaz, Qing Li · 2023 · Cancers
TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma
Xiulei Zhang, Zhihao Fu, Xiao Zhang · 2021 · OncoTargets and Therapy
Investigation on the Potential Correlation Between TP53 and Esophageal Cancer
Lihua Yao, Xiaowu Zhong, Guangcheng Huang, Qiang Ma, Lei Xu, Hong Xiao, Xiaolan Guo · 2021 · Frontiers in Cell and Developmental Biology
Role of miRNAs in Human T Cell Leukemia Virus Type 1 Induced T Cell Leukemia: A Literature Review and Bioinformatics Approach
Caio Bezerra Machado, Leidivan Sousa da Cunha, Jersey Heitor da Silva Maués, Flávia Melo Cunha de Pinho Pessoa, Marcelo Braga de Oliveira, Rodrigo Monteiro Ribeiro, Germison Silva Lopes, Manoel Odorico de Moraes, Maria Elisabete Amaral de Moraes, André Salim Khayat et al. · 2022 · International Journal of Molecular Sciences
Anti-tumor effect of infant-derived Enterococcus via the inhibition of proliferation and inflammation as well as the promotion of apoptosis
Qin Yang, Yao He, Linlin Tian, Zhihong Zhang, Liang Qiu, Xueying Tao, Hua Wei · 2023 · Food & Function
Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC
Maria Stella Franzè, Francesca Saffioti, Vasileios K. Mavroeidis · 2025 · Cancer Drug Resistance
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity
John Davies, Sathya Muralidhar, Juliette A. Randerson‐Moor, Mark Harland, Sally Jane O'Shea, Joey Mark S. Diaz, Christy Walker, Jérémie Nsengimana, Jon P. Laye, Tracey Mell et al. · 2021 · Pigment Cell & Melanoma Research
Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis
Defu Liu, Zhengjun Wang, Li Zhong, Caoyu Xie, Xiaonan Huang, Yaofeng Zhi, Yuzhuo Zhang, Jiaying Liang, Zhenni Shi, Jin Huang et al. · 2022 · Journal of Oncology
Molecular docking of DS-3032B, a mouse double minute 2 enzyme antagonist with potential for oncology treatment development
Vítor Hugo Sales da Mota, Fabrício Freire de Melo, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Kádima Nayara Teixeira · 2022 · World Journal of Clinical Oncology
The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models
Julian Ramelow, Christopher D. Brooks, Li Gao, Abeer Almiman, Terence Marques Williams, Miguel Angel Villalona-Calero, Wenrui Duan · 2020 · BMC Cancer
Multi‐Omic Analysis of Glutamate Excitotoxicity in Primary Neuronal Cultures
Jennifer Nguyen, Xiaolu Zhang, Hunter Eby, Khaled Alganem, William G. Ryan, Ali Sajid Imami, Anna E. Lundh, Anvitha R. Madhavaram, James D. Bretz, Ethel Tackie‐Yarboi et al. · 2025 · Journal of Neurochemistry
Cuproptosis induced by curcumin interfering with proliferation and energy metabolism in colorectal cancer: 3D tumor model and computational simulations reveal curcumin inhibition of HSPD1 and CALCOCO2
Jun‐Feng Cao, Kuan Hang, Hao Zhang, Zuowei Wu, Ziheng Guo, Jie Men, Jinbin Tian, Kezhou Li · 2025 · European Journal of Pharmacology
Inflammatory level under different p53 mutation status and the regulation role of curcumin in tumor microenvironment
Liping Xu, Xiaoli Xie, Xinbo Li, Wenfang Duan, Lei Qiu, Huan Liu, Ying Luo · 2022 · Immunobiology
Genetic alterations shape innate immune cells to foster immunosuppression and cancer immunotherapy resistance
Louis Boafo Kwantwi · 2023 · Clinical and Experimental Medicine
A machine learning and directed network optimization approach to uncover TP53 regulatory patterns
Charalampos P. Triantafyllidis, Alessandro Barberis, Fiona Hartley, Ana Miar, Enio Gjerga, Philip Vincent Charlton, Linda van Bijsterveldt, Julio Sáez-Rodríguez, Francesca Meteora Buffa · 2023 · iScience
Genomic profiling informs therapies and prognosis for patients with hepatocellular carcinoma in clinical practice
Mengqi Song, Haoyue Cheng, Hao Zou, Kai Ma, Lianfang Lu, Qian Wei, Zejiang Xu, Zirui Tang, Yuanzheng Zhang, Yinan Wang et al. · 2024 · BMC Cancer
eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1
Qi Li, Mulun Xiao, Yibo Shi, Jinhao Hu, Tianxiang Bi, Chaoliang Wang, Liang Yan, Xiaoyan Li · 2021 · BMC Cancer
Factors Affecting the Cancer Immunotherapeutic Efficacy of T Cell Bispecific Antibodies and Strategies for Improvement
Meixiao Long, Alice S. Mims, Zihai Li · 2022 · Immunological Investigations
Transcriptional regulation of DLGAP5 by AR suppresses p53 signaling and inhibits CD8+ T cell infiltration in triple-negative breast cancer
Qing Pan, Dachang Ma, Yi Xiao, Kun Ji, Jun Wu · 2024 · Translational Oncology
Identification of lysine lactylation (kla)-related lncRNA signatures using XGBoost to predict prognosis and immune microenvironment in breast cancer patients
Feng Lin, Hang Li, Huan Liu, Jianlin Shen, Lemin Zheng, Shunyi Huang, Yu Chen · 2024 · Scientific Reports
Bridging Tumorigenesis and Therapy Resistance With a Non-Darwinian and Non-Lamarckian Mechanism of Adaptive Evolution
Francesco Catania, Beáta Újvári, Benjamín Roche, Jean‐Pascal Capp, Frédéric Thomas A · 2021 · Frontiers in Oncology
NAIRscore as a biomarker for the quality of immune response to neoantigens is related with an increased overall survival in multiple myeloma
Xingxing Jian, Linfeng Xu, Jingjing Zhao, Yanhui Wang, Wen Zhou, Lu Xie · 2022 · Molecular Therapy — Nucleic Acids
Mutant p53R211* ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune response
Yaling Zeng, Jerome P. L. Ng, Linna Wang, Xiongfei Xu, Betty Yuen Kwan Law, Guobing Chen, Hang Hong Lo, Lijun Yang, Jiujie Yang, Lei Zhang et al. · 2023 · Inflammation Research
A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma
Xiaolan He, Zhengyang Xu, Ruiping Ren, Peng Wan, Yu Zhang, Liangliang Wang, Ying Han · 2023 · Heliyon
Selenium nanoparticle-delivered MDM2 inhibitor reactivates p53 and reprograms tumor immune microenvironment in colorectal cancer
Weiming You, Jun Feng, Litao Guo, Jin Yan, Siqi Yan · 2025 · Frontiers in Immunology
LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression
Jiahao Shi, Xiaoliang Jin, Yihao Wang, Tianyu Zhu, Dongmei Zhang, Qian Li, Xiaomin Zhong, Yaqi Deng, Jianfeng Shen, Xianqun Fan · 2022 · Oncogenesis
Pharmacological Activation of p53 during Human Monocyte to Macrophage Differentiation Attenuates Their Pro-Inflammatory Activation by TLR4, TLR7 and TLR8 Agonists
Dmitry Namgaladze, Bernhard Brüne · 2021 · Cancers
A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer
Cheng Zhang, Cristina Correia, Taylor Weisskittel, Shyang Hong Tan, Kevin Meng-Lin, Grace Yu, Jingwen Yao, Kok Siong Yeo, Shizhen Zhu, Choong Yong Ung et al. · 2022 · Frontiers in Immunology
Transcriptome Analysis Reveals the Multiple Functions of pBD2 in IPEC-J2 Cells against E. coli
Shaoqiang Lian, Xiaqing Lin, Fengting Zhan, Xiaoyang Shen, Yu Liang, Chunli Li · 2022 · International Journal of Molecular Sciences
Expression signature and molecular basis of CDH11 in OSCC detected by a combination of multiple methods
Yuxing Wei, Xujie Cheng, Limei Deng, Hao Dong, Huiping Wei, Cheng Xie, Yangjuan Tuo, Guangyu Li, Dahai Yu, Yong Bing Cao · 2023 · BMC Medical Genomics
Characterization of the m6A regulator-mediated methylation modification patterns in oral squamous cell carcinoma
Lu Pan, He She, Keyi Wang, Wenhui Xia, Haonan Tang, Yuan Fan, Jinhai Ye · 2023 · Scientific Reports
Telomere-Associated Gene Signatures Correlate with Prognosis, Tumor Microenvironment, and Chemosensitivity in Breast Cancer
Yuanyuan Hu, Xiongbin You, Ziwei Zhang, Hong Zhao · 2023 · Medical Science Monitor
RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity
Takashi Morinaka, Nozomu Sakai, Tsukasa Takayashiki, Satoshi Kuboki, Shigetsugu Takano, Gaku Ohira, Hisahiro Matsubara, Masayuki Ohtsuka · 2023 · International Journal of Oncology
A Second Career for p53 as A Broad-Spectrum Antiviral?
Joe B. Harford · 2023 · Viruses
Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing
Kai Xiong, Yuqi Fang, Boyuan Qiu, Chaotao Chen, Nanchang Huang, Feiyuan Liang, Chuangming Huang, Tiantian Lu, Zheng Li, Jinmin Zhao et al. · 2024 · Medical Oncology
Mutational landscape of TP53 and CDH1 in gastric cancer
Hong-Qiao Cai, Liyue Zhang, Li-Ming Fu, Bin Xu, Yan Jiao · 2024 · World Journal of Gastrointestinal Surgery
Fatty acids modulate the colorectal cancer immune microenvironment via regulating the interaction and transactivation of PPARα/δ and P53
Binyan Xu, Xufeng Hou, M X Wang, Lin Qiu, Xiling Chen, Guoming Deng, Daixuan Zhou, Yun Feng, Jinzhao Han, Xiaojing Meng et al. · 2025 · Cell Reports
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53 -Mutated Diffuse Large B-Cell Lymphoma
Manik Uppal, Bhavneet Bhinder, Andrew R. Marderstein, Connie Lee Batlevi, Lorenzo Falchi, Paul Hamlin, Steven Michael Horwitz, Anita Ashok Kumar, Ariela Noy, Andrew David Zelenetz et al. · 2026 · Journal of Clinical Oncology
Targeted therapies for myelodysplastic syndromes/neoplasms (MDS): current landscape and future directions
Aram Bidikian, Jan Philipp Bewersdorf, Rory Michael Shallis, Ted M. Getz, Jessica M. Stempel, Tariq Zuheir Kewan, Maximilian F. Stahl, Amer Methqal Zeidan · 2024 · Expert Review of Anticancer Therapy
Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
Regina Mirgayazova, Raniya Khadiullina, Maria Nikolaevna Filimonova, Vitaly V. Chasov, Emil Bulatov · 2024 · Exploration of Immunology
N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma
Zhilong Huang, Weiting Kang, Qi Zhang · 2022 · Translational Cancer Research
Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma
Ding-Fan Guo, Linwei Fan, Hai-Hui Zeng, Caibin Huang, Xin-Huan Wu · 2023 · Biotechnology and Genetic Engineering Reviews
MiR ‐34 by targeting p53 induces apoptosis and DNA damage in paclitaxel‐resistant human oral squamous carcinoma cells
Bardia Mortezagholi, Kamyar Nasiri, Emad Movahed, Esmaeel Dadgar, Seyedeh Tabasom Nejati, Pardis Hassani, Mahla Esfahaniani, Sona Rafieyan · 2023 · Chemical Biology & Drug Design
Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells
Sharon Shechter, Sapir Ya’ar Bar, Hamdan Khattib, Matthew J. Gage, Dorit Avni · 2023 · Molecules
Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma
Yi Cai, Qianyue Lai, Xuan Zhang, Yu Zhang, Man Zhang, Shaoju Gu, Yuan Qin, Jingshen Hou, Li Zhao · 2023 · Korean Journal of Physiology and Pharmacology
Correlation between KRAS Mutation and CTLA-4 mRNA Expression in Circulating Tumour Cells: Clinical Implications in Colorectal Cancer
Sharmin Aktar, Farhadul Islam, Tracie T. Cheng, Sujani Madhurika Kodagoda Gamage, Indra Neil Choudhury, Md. Sajedul Islam, Cu‐Tai Lu, Faysal Bin Hamid, Hirotaka Ishida, Ichiro Abe et al. · 2023 · Genes
UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma
Kun Zhou, Dexin Wang, Xiaolin Du, Xia Feng, Xiaoxi Zhu, Cheng Wang · 2024 · Acta Biochimica et Biophysica Sinica
Activation of the atypical NF-κB pathway induced by ionizing radiation is not affected by the p53 status
Gracjana Zając, Marek Rusin, Barbara Łasut-Szyszka, Krzysztof Puszyński, Piotr Widłak · 2022 · Acta Biochimica Polonica
Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer
Xiaofei Xu, Limei Xie, Liwei Meng, Shangzhen Geng, Jin Liu, Xiangting Cao, Zhaogang Dong, Zhaoquan Xing · 2022 · BioScience Trends
Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness
Xiugai Li, Chang Zheng, Xiaoxia Xue, Junying Wu, Fei Li, Dan Song, Xuelian Li · 2023 · Functional & Integrative Genomics
Attenuation of aggressive tumor progression of anaplastic thyroid cancer by p53
Eunmi Hwang · 2024 · American Journal of Cancer Research
Transplant options and outcomes for TP53 myeloid disease
Hugo Francisco Fernandez, Asmita Mishra · 2024 · Hematology
The PURB–HOTAIR complex regulates p53-dependent promoter-specific transcriptional activation
Zhangchuan Xia, Ning Kon, Zhenyi Su, Jingjie Yi, Hua zi Xu, Hui Zhou, Zhiguo Zhang, Wei Jun Gu · 2025 · Nature Structural & Molecular Biology
Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies
H. Helena Wu, Sarah Leng, David D. Eisenstat, Consolato Maria Sergi, Roger P. Leng · 2026 · Cellular & Molecular Biology Letters
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway
Zheng Hu, Ji Ma, Danni Gong, Ruijing Feng, Xin Wang, Hongwei Chen, Chen Cao, Ting Liu, Tong Zhao, Huang Chen et al. · 2022 · Current Cancer Drug Targets
Insight from sirtuins interactome: topological prominence and multifaceted roles of SIRT1 in modulating immunity, aging and cancer
Nur Diyana Zulkifli, Nurulisa Zulkifle · 2023 · Genomics & Informatics
Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
Xueting Cao, Boya Wu, Yingzheng Hou, Jing Chen · 2023 · Translational Cancer Research
Low Expression MCEMP1 Promotes Lung Adenocarcinoma Progression and its Clinical Value
Liqun Ling, Tianqi Hu, Chenkang Zhou, Shuhui Chen, Lunan Chou, Yuxin Chen, Zhaoting Hu, Kate Huang, Jie Chen, Yumin Wang et al. · 2024 · Current Cancer Drug Targets
MRPL41, as a target for acupuncture, promotes neuron apoptosis in models of ischemic stroke via activating p53 pathway
Hong Wei Guo, Yuanwei Dong, Danqing Luo, Meng Gong, Jianfeng Sun, Zhipeng Wu, Zhixiang Liu, Lei Zhong, Song Jin · 2024 · Neurochemistry International
Chromatin Immunoprecipitation Reveals p53 Binding to G-Quadruplex DNA Sequences in Myeloid Leukemia Cell Lines
Libuše Kratochvilová, Alessandra Dinová, Natália Valková, Michaela Dobrovolná, Pedro A. Sánchez‐Murcia, Václav Brázda · 2025 · ACS Bio & Med Chem Au
Restoring Tumor Cell Immunogenicity Through Ion‐Assisted p53 mRNA Domestication for Enhanced In Situ Cancer Vaccination Effect
Yan Liang, Jingge Zhang, Jinjin Wang, Yuhe Renee Yang, Xinyu Tan, Shuguang Li, Zhenzhen Guo, Zhenzhong Zhang, Junjie Liu, Jinjin Shi et al. · 2025 · Advanced Science
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
Chie Kudo‐Saito, Narikazu Boku, Hidekazu Hirano, Hirokazu Shoji · 2022 · Frontiers in Immunology
Lactobacillus casei enhances the apoptosis inducing effect of geniposide on U87 human glioma cells in vitro
Fei CHEN, Zhipeng Teng, Xing Peng, Haibo Wu, Wenwu Wan, Haibo Long · 2023 · Food Science and Technology
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer
Ferdynand J. Kos, Paul Henry Frankel, Mihaela C. Cristea, Melissa Eng, Raechelle Tinsley, Shannon Dempsey, Nora H. Ruel, Daphne B. Stewart, Thanh Hue Dellinger, Don J. Diamond · 2023 · Cancer Research Communications
WD repeat domain 76 predicts poor prognosis in lower grade glioma and provides an original target for immunotherapy
Xingbo Cheng, Zhendong Liu, Haigang Chang, Wenjia Liang, Pengxu Li, Yanzheng Gao · 2024 · European journal of medical research
A Narrative Review of the TP53 and Its Product the p53 Protein
Behzad Foroutan · 2023 · OBM Genetics